Literature DB >> 31941771

HIV-1 Vpu Downregulates Tim-3 from the Surface of Infected CD4+ T Cells.

Jérémie Prévost1,2, Cassandra R Edgar3, Jonathan Richard1,2, Steven M Trothen3, Rajesh Abraham Jacob3, Mitchell J Mumby3, Suzanne Pickering4, Mathieu Dubé1, Daniel E Kaufmann1,5, Frank Kirchhoff6, Stuart J D Neil4, Andrés Finzi7,2,8, Jimmy D Dikeakos9.   

Abstract

Along with other immune checkpoints, T cell immunoglobulin and mucin domain-containing protein 3 (Tim-3) is expressed on exhausted CD4+ and CD8+ T cells and is upregulated on the surface of these cells upon infection by human immunodeficiency virus type 1 (HIV-1). Recent reports have suggested an antiviral role for Tim-3. However, the molecular determinants of HIV-1 which modulate cell surface Tim-3 levels have yet to be determined. Here, we demonstrate that HIV-1 Vpu downregulates Tim-3 from the surface of infected primary CD4+ T cells, thus attenuating HIV-1-induced upregulation of Tim-3. We also provide evidence that the transmembrane domain of Vpu is required for Tim-3 downregulation. Using immunofluorescence microscopy, we determined that Vpu is in close proximity to Tim-3 and alters its subcellular localization by directing it to Rab 5-positive (Rab 5+) vesicles and targeting it for sequestration within the trans- Golgi network (TGN). Intriguingly, Tim-3 knockdown and Tim-3 blockade increased HIV-1 replication in primary CD4+ T cells, thereby suggesting that Tim-3 expression might represent a natural immune mechanism limiting viral spread.IMPORTANCE HIV infection modulates the surface expression of Tim-3, but the molecular determinants remain poorly understood. Here, we show that HIV-1 Vpu downregulates Tim-3 from the surface of infected primary CD4+ T cells through its transmembrane domain and alters its subcellular localization. Tim-3 blockade increases HIV-1 replication, suggesting a potential negative role of this protein in viral spread that is counteracted by Vpu.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  HIV; Tim-3; Vpu; membrane trafficking; viral release

Mesh:

Substances:

Year:  2020        PMID: 31941771      PMCID: PMC7081912          DOI: 10.1128/JVI.01999-19

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  75 in total

1.  Determinants of tetherin antagonism in the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein.

Authors:  Raphaël Vigan; Stuart J D Neil
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

2.  Increased CD95/Fas-induced apoptosis of HIV-specific CD8(+) T cells.

Authors:  Y M Mueller; S C De Rosa; J A Hutton; J Witek; M Roederer; J D Altman; P D Katsikis
Journal:  Immunity       Date:  2001-12       Impact factor: 31.745

3.  Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus.

Authors:  H Kestler; T Kodama; D Ringler; M Marthas; N Pedersen; A Lackner; D Regier; P Sehgal; M Daniel; N King
Journal:  Science       Date:  1990-06-01       Impact factor: 47.728

4.  CTLA4 mediates antigen-specific apoptosis of human T cells.

Authors:  J G Gribben; G J Freeman; V A Boussiotis; P Rennert; C L Jellis; E Greenfield; M Barber; V A Restivo; X Ke; G S Gray
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

5.  Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.

Authors:  Suzanne L Topalian; F Stephen Hodi; Julie R Brahmer; Scott N Gettinger; David C Smith; David F McDermott; John D Powderly; Richard D Carvajal; Jeffrey A Sosman; Michael B Atkins; Philip D Leming; David R Spigel; Scott J Antonia; Leora Horn; Charles G Drake; Drew M Pardoll; Lieping Chen; William H Sharfman; Robert A Anders; Janis M Taube; Tracee L McMiller; Haiying Xu; Alan J Korman; Maria Jure-Kunkel; Shruti Agrawal; Daniel McDonald; Georgia D Kollia; Ashok Gupta; Jon M Wigginton; Mario Sznol
Journal:  N Engl J Med       Date:  2012-06-02       Impact factor: 91.245

Review 6.  PD-1 and CTLA-4 inhibitory cosignaling pathways in HIV infection and the potential for therapeutic intervention.

Authors:  Daniel E Kaufmann; Bruce D Walker
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

7.  Resistance to type 1 interferons is a major determinant of HIV-1 transmission fitness.

Authors:  Shilpa S Iyer; Frederic Bibollet-Ruche; Scott Sherrill-Mix; Gerald H Learn; Lindsey Plenderleith; Andrew G Smith; Hannah J Barbian; Ronnie M Russell; Marcos V P Gondim; Catherine Y Bahari; Christiana M Shaw; Yingying Li; Timothy Decker; Barton F Haynes; George M Shaw; Paul M Sharp; Persephone Borrow; Beatrice H Hahn
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-09       Impact factor: 11.205

8.  HIV-1 Vpu blocks recycling and biosynthetic transport of the intrinsic immunity factor CD317/tetherin to overcome the virion release restriction.

Authors:  Sarah Schmidt; Joëlle V Fritz; Julia Bitzegeio; Oliver T Fackler; Oliver T Keppler
Journal:  mBio       Date:  2011-05-24       Impact factor: 7.867

9.  Single-cell characterization and quantification of translation-competent viral reservoirs in treated and untreated HIV infection.

Authors:  Marion Pardons; Amy E Baxter; Marta Massanella; Amélie Pagliuzza; Rémi Fromentin; Caroline Dufour; Louise Leyre; Jean-Pierre Routy; Daniel E Kaufmann; Nicolas Chomont
Journal:  PLoS Pathog       Date:  2019-02-27       Impact factor: 6.823

10.  Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking.

Authors:  Richard S Mitchell; Chris Katsura; Mark A Skasko; Katie Fitzpatrick; David Lau; Autumn Ruiz; Edward B Stephens; Florence Margottin-Goguet; Richard Benarous; John C Guatelli
Journal:  PLoS Pathog       Date:  2009-05-29       Impact factor: 6.823

View more
  9 in total

1.  Bimolecular Fluorescence Complementation to Visualize Protein-Protein Interactions in Cells.

Authors:  Cassandra R Edgar; Jimmy D Dikeakos
Journal:  Methods Mol Biol       Date:  2022

2.  Detection of the HIV-1 Accessory Proteins Nef and Vpu by Flow Cytometry Represents a New Tool to Study Their Functional Interplay within a Single Infected CD4+ T Cell.

Authors:  Jérémie Prévost; Jonathan Richard; Romain Gasser; Halima Medjahed; Frank Kirchhoff; Beatrice H Hahn; John C Kappes; Christina Ochsenbauer; Ralf Duerr; Andrés Finzi
Journal:  J Virol       Date:  2022-01-26       Impact factor: 6.549

Review 3.  Immune checkpoint blockade in HIV.

Authors:  Celine Gubser; Chris Chiu; Sharon R Lewin; Thomas A Rasmussen
Journal:  EBioMedicine       Date:  2022-02-02       Impact factor: 8.143

Review 4.  Role of Viral Protein U (Vpu) in HIV-1 Infection and Pathogenesis.

Authors:  Nabab Khan; Jonathan D Geiger
Journal:  Viruses       Date:  2021-07-27       Impact factor: 5.048

5.  Flow-Cytometry Intracellular Detection and Quantification of HIV1 p24 Antigen and Immunocheckpoint Molecules in T Cells among HIV/AIDS Patients.

Authors:  Belay Tessema; Andreas Boldt; Brigitte König; Melanie Maier; Ulrich Sack
Journal:  HIV AIDS (Auckl)       Date:  2022-08-04

Review 6.  HIV-1 Hijacking of Host ATPases and GTPases That Control Protein Trafficking.

Authors:  Lucas A Tavares; Yunan C Januário; Luis L P daSilva
Journal:  Front Cell Dev Biol       Date:  2021-07-08

7.  Differential Vpu-Mediated CD4 and Tetherin Downregulation Functions among Major HIV-1 Group M Subtypes.

Authors:  Zabrina L Brumme; Mark A Brockman; Gisele Umviligihozo; Kyle D Cobarrubias; Sandali Chandrarathna; Steven W Jin; Nicole Reddy; Helen Byakwaga; Conrad Muzoora; Mwebesa B Bwana; Guinevere Q Lee; Peter W Hunt; Jeff N Martin; Chanson J Brumme; David R Bangsberg; Etienne Karita; Susan Allen; Eric Hunter; Thumbi Ndung'u
Journal:  J Virol       Date:  2020-07-01       Impact factor: 5.103

8.  HIV-1 Vpu Promotes Phagocytosis of Infected CD4+ T Cells by Macrophages through Downregulation of CD47.

Authors:  Lijun Cong; Scott M Sugden; Pascal Leclair; Chinten James Lim; Tram N Q Pham; Éric A Cohen
Journal:  mBio       Date:  2021-08-24       Impact factor: 7.867

Review 9.  Expression Profile and Biological Role of Immune Checkpoints in Disease Progression of HIV/SIV Infection.

Authors:  Yuting Sun; Jing Xue
Journal:  Viruses       Date:  2022-03-11       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.